Journals

Journal Cardiovascular Disorder and Medicine (Cardiovasc Dis Med) (ISSN 2806-1330)

Aims and Scope

Cardiovascular Disorder and Medicine is an international, scholarly multidisciplinary peer reviewed, open access journal which considers papers on all areas of cardiovascular system specifically focusing on diagnosis, prevention, management and treatment of heart disorders. The scope of the journal covers topics including but not limited to hypertensive heart disease, psychological stress and cardiovascular disease risk, biomarkers and cardiovascular risk prediction, vitamin d and cardiovascular disease, preventive cardiology, valvular heart disease as well as related molecular and cell biology, genetics, pathophysiology, epidemiology, and controlled trials.

Cardiovascular Disorder and Medicine features original research article, review article, book review, clinical case study, clinical trial, data report, evidence based medical research reports, observational studies, editorial, hypothesis & theory, methods, mini review, opinion, original research, perspective studies, commentaries, review and technology report.

The Journal is particularly interested in studies describing state-of-the art experimental designs and new technologies, as well as studies of interdisciplinary nature. All articles published by Cardiovascular Disorder and Medicine are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers.

All the work at Science Repository is licensed under a Creative Commons Attribution 4.0 International License. Authors at Science Repository retain copyright to their work and allow others to copy, distribute, transmit, and adapt their work, provided proper attribution is given.

   
This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. View License Deed | View Legal Code

NLM ID: 101768935

For submission authors can directly submit manuscript to [email protected]

 

Manuscripts number will be provided to the corresponding author within 72 hours for the respective manuscript submitted.

  • 14 day review process with international peer-review standards
  • Timeline of processing from Submission to Publication is 30 days
  • Manuscript will be published within 7 days of acceptance

Editor-in-chief

TAKUYA WATANABE

Professor of Medical Science

Laboratory of Cardiovascular Medicine

Tokyo University

Japan

Biography

Dr. Takuya Watanabe Graduated from Showa University School of Medicine in 1991 and passed National Board Examination for MD, 1991 Research Fellow, Division of Cardiology, Nakano National Chest Hospital, Tokyo, Japan, 1992-1993 Graduated from Showa University Graduate School of Medical Sciences and obtained PhD in medicine in 1997 Clinical Assistant, Third Department of Internal Medicine, Division of Cardiology, Showa University School of Medicine, Tokyo, Japan, 1997-1998 Postdoctoral Fellow, Department of Internal Medicine, Division of Cardiology, University of Texas-Houston Health Science Center, Houston, Texas, USA, 1998-2001 Chief, Division of Internal Medicine, Showa University Karasuyama Hospital, Tokyo Japan (2001-2003) Assistant Professor, Department of Internal Medicine, Division of Cardiology, Showa University School of Medicine, Tokyo, Japan, 2003-2004 Associate Professor, Department of Biochemistry, Showa University School of Medicine, Tokyo, Japan, 2004-2009 Professor, Laboratory of Cardiovascular Medicine, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan, 2010.

Research Interest: Geriatrics and Cardiovascular Medicine (Roles of Vasoactive Agents in Hypertension, Atherosclerosis, and Ischemic Heart and Cerebrovascular Diseases). Recently, the focus of my research is the pathogenetic roles of vasoactive peptides discovered recently, such as human urotensin II, salusins, heregulins, and incretins in atherosclerosis and its complications.

Editorial board

Robert J Chilton

Professor

Department of Medicine, San Antonio

University of Texas Health Science Center

United States

Edimar Alcides Bocchi

Associate Professor

Cardiopulmonary Department

São University Medical School

Brazil

Takuya Watanabe

Professor of Medical Science

Laboratory of Cardiovascular Medicine

Tokyo University

Japan

Donna Wang

Professor

Department of Medicine

Michigan State University

United States

Wilbert S. Aronow

Professor

Director of Cardiology Research

New York Medical College/Westchester Medical Center

United States

Ajay Kumar Sharma

Research Fellow

Cardiovascular Diseases

Massachusetts General Hospital , Harvard Medical School Boston Massachusetts

United States

Sasikanth Adigopula

Medical Director, Heart Failure

Punzi Medical Center

Texas, United States

Harm Wienbergen

Department of Cardiology

Bremen heart foundation

Germany

Mehmet OC

Department of Cardiovascular Surgery

Selcuk University Faculty of Medicine

Turkey

Ali Dahhan

Department of Internal Medicine

Carver College of Medicine , University of Iowa

United States

Praxis Cocco

Cardiology Office

Rheinfelden

Switzerland

Pachon M JC

Pacemaker and Arrhythmias

Dante Pazzanese Cardiology Institute and Sao Paulo Heart Hospital

Brazil

Muhammed Keskin

Siyami Ersek Thoracic and Cardiovascular Surgery Center Training and Research Hospital Department of Cardiology

Turkey

Vijo Poulose

Department of Respiratory Medicine

Changi General Hospital

Singapore

Salim Surani

Division of Pulmonary

Critical Care & Sleep Medicine Texas A&M University, Health Science Center

United States

Brian Wang

Department of Cellular Electrophysiology

National Heart and Lung Institute , Imperial Center for Translational and Experimental Medicine

United Kingdom

Preethi Ramachandran

Department of Hematology and Oncology

Brookdale University Medical Center

United States

Current Issue Volume 2, Issue 1

Cardiovascular Disease among Breast Cancer Survivors


FGF23 and Immune Activation are Correlated in Chronic Heart Failure and Additive Predictors of Poor Prognosis


Personality Disorder as the Initial Presentation of a Complicated Endocarditis: Diagnostic Challenges in the CARDIO-PSYCHIATRY


Lifestyle Risk Factors and Management of Obesity: A Mini Review


Doppler Ultrasonography Screening of the Lower Limbs in Patient with Coronary Artery Disease


Knowledge, Attitudes, Practices and Blood Pressure Control of Hypertensive Patients at a South African Primary Health Care Centre


Epidemiological and Clinical Features of 156 Cases of COVID-19: A Prospective Study in Algerian Population


Submit Manuscript

You can submit your manuscript at Science Repository. Authors submit manuscript files and metadata & can request for revision. Editors use the system to review submissions, assign to reviewers, and make and communicate decisions to accept, revise, transfer or reject manuscripts. Reviewers are invited to work on manuscripts, can accept or reject assignments.

For submission authors can directly submit manuscript to [email protected]

Manuscripts number will be provided to the corresponding author within 72 hours for the respective manuscript submitted.

  • 14 day review process with international peer-review standards
  • Timeline of processing from Submission to Publication is 30 days
  • Manuscript will be published within 7 days of acceptance

Publication Charges

Cardiovascular Disorder and Medicine is an Open Access journal and we do not charge the end user when accessing a manuscript or any article. This allows the scientific community to view, download, distribution of an article in any medium, provided that the original work is properly cited, under the term of "Creative Commons Attribution License".

In line with other open access journals we provide a flat fee submission structure on the acceptance of a peer-reviewed article which covers in part the entirety of the publication pathway (the article processing charge). The process includes our maintenance, submission and peer review systems and international editing, publication and submission to global indexing and tracking organisations and archiving to allow instant access to the whole article and associated supplementary documents. We also have to ensure enough investment to secure a sustainable model which ethically, legally and financially stable.

The publication charges for Cardiovascular Disorder and Medicine are £ (GBP) 1099.

Frequently Asked Questions (FAQs)

Why do we charge?

All articles published in Science Repository are open access. Open Access publishing implies that all readers, anywhere in the world, are allowed unrestricted to full text of articles, immediately on publication in Science Repository Journals. The Article Publication Charges pay for the editorial and production costs of the journal, for hosting the website, publishing articles online, preparing HTML , PDF and XML versions of the articles and submitting the articles in electronic citation database like CrossRef.

Our financial goals are to:

  • Maintain the portal for best experienece
  • Recover capitalization cost
  • Produce sufficient revenue to allow for a sustainable and scalable publishing program, under continuous development
  • Although we charge the minimum possible but we will reduce the publication-charge cost downward over time.

When should I pay?

Corresponding author or the paying institutions should arrange for the payment once they are notified regarding acceptance of the article. APC is exempted for cases in which a wavier agreement has been made in-prior to submission.

*We request an immediate attention towards the payment as the articles will not be published unless the charges have been paid.

Who will pay the APC (Article Processing Charges)?

Corresponding author or Co-authors has to make the payment on acceptance of the article.

How do I pay?

Authors or institutions can make payments by two modes as per their convenience.

  • Online Card payment

Note: No taxes are included in this charge, taxes will be applicable as per the policies of the country of the payee. Additional transaction gateway charges may be levied on the payee.

Do I have to pay if my manuscript is rejected?

No, Article processing charges will not be applicable for articles rejected by the Editorial office.

Can I be eligible for wavier on APC?

The waiver request will be considered on a case-by-case basis, and will be provided accordingly.

*The Waiver requests must be made during the submission process and will not be accepted after processing of the manuscript.

Withdrawal Charges

Please check our Refund Policy

Are reprints of my article included in the article processing charges (APCs)?

No, Article processing charges (APCs) do not include the charges for the reprints. Reprints facility is optional and should be order separately.

For more details you can refer to FAQs or contact us [email protected]

Archive